Dad is HER2 negative - is this "good" "bad" or "indifferent"?
Would love to know the thoughts on this from some of you who know more than we do.
Thanks!
Comments
-
My dad also tested negative
My dad also tested negative for the HER2 receptor, we were dissapointed but understood that only a small number of individuals have positive receptors. This is just one treatment option and although promising the fact that your dad didn't test positive shouldn't mean anything for his long term prognosis or how he will respond to treatment. How he responds to chemo is an individual thing and each person is different.
The HER2 type of treatment targets specific tumor characteristics. It was initally approved for use in Breast Cancer patients. The FDA just formally approved herceptin for treatment in EC this fall. The HER2 test only provides an indicator if a specific targeted treatment (the use of herceptin) can be used to target the tumor. NOT whether or not you will respond to chemo. My understanding is that approximately 20% of all EC patients test positive for the HER2 receptor, that cetainly isn't a majority. Further there are inconclusive studies that have shown people with the HER2 receptor do worse than other patients, and studies that show they do better.
We have several survivors on this board who have tested positive for the HER2 receptor and responded favorably to the Herceptin treatment. But don't worry that your dad can't have this particular treatment, there are other weapons available in this fight. Keep the faith and hope.
Good luck and keep asking questions.
Cindy0 -
Thank youunclaw2002 said:My dad also tested negative
My dad also tested negative for the HER2 receptor, we were dissapointed but understood that only a small number of individuals have positive receptors. This is just one treatment option and although promising the fact that your dad didn't test positive shouldn't mean anything for his long term prognosis or how he will respond to treatment. How he responds to chemo is an individual thing and each person is different.
The HER2 type of treatment targets specific tumor characteristics. It was initally approved for use in Breast Cancer patients. The FDA just formally approved herceptin for treatment in EC this fall. The HER2 test only provides an indicator if a specific targeted treatment (the use of herceptin) can be used to target the tumor. NOT whether or not you will respond to chemo. My understanding is that approximately 20% of all EC patients test positive for the HER2 receptor, that cetainly isn't a majority. Further there are inconclusive studies that have shown people with the HER2 receptor do worse than other patients, and studies that show they do better.
We have several survivors on this board who have tested positive for the HER2 receptor and responded favorably to the Herceptin treatment. But don't worry that your dad can't have this particular treatment, there are other weapons available in this fight. Keep the faith and hope.
Good luck and keep asking questions.
Cindy
Cindy - for your reply0 -
It might be good that he's negative
Good question. Testing positive means the tumor cells over-express (over-produce?) the HER2 gene. The drug Herceptin has been shown to be effective in suppressing this gene. Testing negative means your dad would not benefit from the drug Herceptin.
On the other hand, overexpression of HER2, at least in breast cancer patients, is associated with increased disease recurrence and worse prognosis. Seems to me that it's better not to test positive for it to begin with. Perhaps it's better to have a less aggressive disease than to have a more aggressive disease that responds to the drug?0 -
Thank you Callaloo. That isCallaloo said:It might be good that he's negative
Good question. Testing positive means the tumor cells over-express (over-produce?) the HER2 gene. The drug Herceptin has been shown to be effective in suppressing this gene. Testing negative means your dad would not benefit from the drug Herceptin.
On the other hand, overexpression of HER2, at least in breast cancer patients, is associated with increased disease recurrence and worse prognosis. Seems to me that it's better not to test positive for it to begin with. Perhaps it's better to have a less aggressive disease than to have a more aggressive disease that responds to the drug?
Thank you Callaloo. That is the mindset we had when we first learned of the gene but once the assistant doctor made that comment we began to question it.
Thanks for your reply.0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 734 Skin Cancer
- 654 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards